Canopy Growth (CGC) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Canopy Growth

NasdaqGS•Healthcare•Drug Manufacturers - Specialty & Generic

$0.97-0.01(-0.01%)Pre-market

Market Cap

$407.91M

P/S

1.1x

P/B

0.6x

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel. It also provides vaporizers and accessories; dried flower and pre-rolled joints, oil, and vapes and beverages; extracts and concentrates, such as softgel capsules; and cannabis edibles, including gummies. In addition, the company operates e-commerce shop; medical cannabis online distribution platform; and an online medical cannabis clinic. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Abba Medix, Storz & Bickel, Wana, and Claybourne, Apollo, Canada House, R'belle, LowKey, MTL Cannabis, DeeLish, DOJA brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.

How this company scores

WeakMetricSide Score: 54/100

Grade capped at D — Interest coverage below 1× (-3.2x) — earnings cannot cover interest. Strongest: Profitability (17/25); weakest: Cash & Earnings Quality (4/25).

Profitability17/25

Growth16/25

Balance Sheet & Red Flags17/25

Cash & Earnings Quality4/25

Strengths

Long cash runwayLow leverageProfit converts from growthImproving leverage

Grade capped at D

Interest coverage below 1× (-3.2x) — earnings cannot cover interest.

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/S · 1.1x5y range 0.3x – 9.4x

Currently near its 20-quarter median.

P/B · 0.6x5y range 0.2x – 1.4x

Currently below its 20-quarter median.

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Red Flag

Free cash flow has been negative in 8 of the last 8 quarters — earnings are not translating to cash.

Price & Volume

Market Cap $407.91M

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $358.44M
Q. Revenue: $100.36M
TTM EBITDA: $-141.52M
TTM Op. Income: $-161.15M
Q. Op. Income: $-22.11M
TTM Net Income: $-235.96M
Q. Net Income: $-14.58M
EPS: $-0.03
Shares Out.: $422.26M

$358.44M in TTM revenue grew 9.6% YoY, reaching $100.36M last quarter. TTM EBITDA of $-141.52M and TTM operating income of $-161.15M show growth is flowing through to the bottom line. However, net income is negative at $235.96M — growth is not yet reaching the bottom line. Across the last 8 quarters, TTM revenue has risen for 6 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 22.2%
EBITDA Margin: -16.7%
Op. Margin: -22.0%
Net Margin: -14.5%

Op. margin of -22.0% is up 3.5% YoY — cost efficiency is improving. Net margin at -14.5% and gross margin of 22.2% show how much of each revenue dollar survives to profit. Over the past year, operating margin is up 14% — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: N/A
P/S Ratio: 1.1x
P/B Ratio: 0.6x

P/S of 1.1x and P/B of 0.6x. P/S is low relative to typical market levels.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $1.10B
Cash: $336.63M
Long-Term Debt: $211.38M
Book Value: $688.63M
D/E Ratio: 0.3
Debt/EBITDA: N/A

With $1.10B in assets and $211.38M in long-term debt, D/E is 0.3and book value is $688.63M — a conservative capital structure with a cushion to weather downturns. Over the past year, debt/equity is down 48% — an improving trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $-25.01M
TTM Free Cash Flow: $-83.24M
FCF Margin: -23.2%
FCF / Net Income: 0.4

TTM FCF of $-83.24M on $-25.01M in operating cash flow. The FCF / Net Income ratio of 0.4x means cash covers only part of net income — earnings quality needs attention. Over the past year, free cash flow is up 37% — a weakening trend.